These findings suggest that higher levels of APP, whether it be higher levels of the beta‐amyloid peptide, the extracellular or cytoplasmic fragments, and/or full‐length APP, are correlated with early‐onset Alzheimer's disease. Here, APP is linked to Alzheimer disease.